Status:
RECRUITING
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Graft-versus-leukemia
Graft vs Host Disease
Eligibility:
All Genders
7-80 years
Brief Summary
This study will provide follow-up evaluation and care of patients who have undergone allogeneic (donor) stem cell transplantation at the NIH Clinical Center. Patients are monitored for their response ...
Detailed Description
While patients surviving more than three years from SCT have a high probability of being cured of their underlying disease, they are still at risk from several categories of complications which could ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA-TRANSPLANT RECIPIENTS:
- Patients surviving three years or more from date of first stem cell transplant who have been treated.
- With an experimental allogeneic stem cell transplant on a NHLBI HB protocol
- Or
- With a standard of care allogeneic stem cell transplant on an NHLBI protocol
- Or
- Selectively, when the allogenic transplant was conducted outside the NIH, but the subject has a special condition of interest to the research team
- Age greater than or equal to 7 years old and age less than or equal to 80
- For adults: Ability to comprehend the investigational nature of the study and provide informed consent. For minors: Written informed consent from one parent or guardian and informed assent: The process will be explained to the minor on a level of complexity appropriate for their age and ability to comprehend.
- EXCLUSION CRITERIA-STEM CELL TRANSPLANT RECIPIENTS:
- None, all patients meeting the inclusion criteria will be eligible
Exclusion
Key Trial Info
Start Date :
April 22 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00106925
Start Date
April 22 2005
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892